DK260687A - Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf - Google Patents

Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf

Info

Publication number
DK260687A
DK260687A DK260687A DK260687A DK260687A DK 260687 A DK260687 A DK 260687A DK 260687 A DK260687 A DK 260687A DK 260687 A DK260687 A DK 260687A DK 260687 A DK260687 A DK 260687A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
immunoglobulin conjugates
conjugates
immunoglobulin
Prior art date
Application number
DK260687A
Other languages
English (en)
Other versions
DK260687D0 (da
Inventor
Bennett Coleman Laguzza
Cynthia Lynn Nichols
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK260687D0 publication Critical patent/DK260687D0/da
Publication of DK260687A publication Critical patent/DK260687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK260687A 1986-05-27 1987-05-22 Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf DK260687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86718386A 1986-05-27 1986-05-27

Publications (2)

Publication Number Publication Date
DK260687D0 DK260687D0 (da) 1987-05-22
DK260687A true DK260687A (da) 1987-11-28

Family

ID=25349292

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260687A DK260687A (da) 1986-05-27 1987-05-22 Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf

Country Status (13)

Country Link
EP (1) EP0247792A3 (da)
JP (1) JPS62287000A (da)
KR (1) KR900006908B1 (da)
CN (1) CN87104430A (da)
AU (1) AU600727B2 (da)
CA (1) CA1288896C (da)
DK (1) DK260687A (da)
HU (1) HUT44033A (da)
IL (1) IL82579A0 (da)
NZ (1) NZ220441A (da)
PT (1) PT84932B (da)
SU (1) SU1561825A3 (da)
ZA (1) ZA873600B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728856D0 (en) * 1987-12-10 1988-01-27 Bradwell A R Tumour-locating agents & method of locating tumours
ZA89524B (en) * 1988-01-27 1990-09-26 Lilly Co Eli Antibody conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5010176A (en) * 1988-11-10 1991-04-23 Eli Lilly And Company Antibody-drug conjugates
IL93986A0 (en) * 1989-04-04 1991-01-31 Lilly Co Eli Improvements in and relating to pharmaceutical formulations
KR100208957B1 (ko) * 1990-04-25 1999-07-15 로렌스 티. 마이젠헬더 신규한 cc-1065 유사체
AU708475B2 (en) * 1995-10-18 1999-08-05 Merck & Co., Inc. Conjugates useful in the treatment of benign prostatic hyperplasia
WO2002085908A1 (en) 2001-04-24 2002-10-31 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
CA2484640C (en) 2002-05-15 2012-01-17 Endocyte, Inc. Vitamin-mitomycin conjugates
JP5576007B2 (ja) 2003-01-27 2014-08-20 エンドサイト・インコーポレイテッド ビタミン受容体結合性薬剤送達結合体
JP5149620B2 (ja) 2004-07-23 2013-02-20 エンドサイト，インコーポレイテッド ２価リンカーおよびその結合体
WO2006101845A2 (en) 2005-03-16 2006-09-28 Endocyte, Inc. Synthesis and purification of pteroic acid and conjugates thereof
JP2009504783A (ja) 2005-08-19 2009-02-05 エンドサイト，インコーポレイテッド ビンカアルカロイド、類似体および誘導体のリガンド結合体
EP2374480A3 (en) 2005-08-19 2013-05-01 Endocyte, Inc. Mutli-drug ligand conjugates
US20100104626A1 (en) 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
NZ580132A (en) 2007-03-14 2012-11-30 Endocyte Inc Binding ligand linked drug delivery conjugates of tubulysins to vitamins
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CN104383553A (zh) 2007-06-25 2015-03-04 恩多塞特公司 含有亲水性间隔区接头的共轭物
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
JP2015536323A (ja) 2012-10-16 2015-12-21 エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． 非天然アミノ酸を含む薬物送達結合体および使用方法
CN108948128B (zh) * 2018-07-02 2021-10-01 中国科学技术大学 一种基于缺电子苯甲醛的无催化剂腙连接多肽或蛋白质化学修饰方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI820020L (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobulinkonjugater
EP0121388B1 (en) * 1983-03-30 1990-06-13 Lilly Industries Limited Immunoglobulin conjugates
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
ATE89567T1 (de) * 1985-11-12 1993-06-15 Wallone Region Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
CN87104430A (zh) 1988-05-11
CA1288896C (en) 1991-09-10
EP0247792A3 (en) 1989-07-12
PT84932A (en) 1987-06-01
AU600727B2 (en) 1990-08-23
JPS62287000A (ja) 1987-12-12
PT84932B (pt) 1990-02-08
AU7334987A (en) 1987-12-03
SU1561825A3 (ru) 1990-04-30
ZA873600B (en) 1988-12-28
NZ220441A (en) 1989-09-27
EP0247792A2 (en) 1987-12-02
DK260687D0 (da) 1987-05-22
HUT44033A (en) 1988-01-28
KR870011132A (ko) 1987-12-21
KR900006908B1 (ko) 1990-09-24
IL82579A0 (en) 1987-11-30

Similar Documents

Publication Publication Date Title
DK665187D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK260687D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK8787A (da) Indolderivater og fremgangsmaade til fremstilling deraf
DK522487A (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK3687A (da) Polypeptider og fremgangsmaade til fremstilling deraf
DK134288A (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK335986D0 (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK397788A (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK362987A (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK487688A (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK624588A (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK290187D0 (da) Peptidderivater og fremgangsmaade til fremstilling deraf
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment